The Non-Malignant Diseases Working Committee provides scientific oversight for studies related to hematopoietic cell transplantation and gene therapy/gene editing for immune deficiencies, inborn errors of metabolism, autoimmune diseases, aplastic anemia, hemoglobinopathy, and other non-malignant hematopoietic disorders.
Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.
The TCT® Trademark belongs to the Cardiovascular Research Foundation. ASTCT, CIBMTR, MCW, NMDP, the 2019, 2020, and 2021 TCT Conferences and materials are NOT affiliated with or sponsored by Cardiovascular Research Foundation.